Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
wolf-screen-ratio-mammosphere-adherent | 0.944 | 7.33e-16 | 2.03e-03 | 3.48e-02 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
RPA2 | 6118 | 98 | 1.250 | 1.151 | 69 | Yes | - |
[ PTGS2 ] | 5743 | 1 | -0.242 | 0.944 | 14 | - | Yes |
EIF2S2 | 8894 | 27 | 1.075 | 1.138 | 81 | Yes | - |
PSMD1 | 5707 | 12 | 0.836 | 1.057 | 113 | Yes | - |
RBX1 | 9978 | 97 | 1.185 | 1.151 | 139 | Yes | - |
PSMA2 | 5683 | 60 | 1.093 | 1.106 | 89 | Yes | - |
PSMD3 | 5709 | 57 | 0.986 | 1.106 | 146 | Yes | - |
PSMB7 | 5695 | 48 | 0.982 | 1.052 | 57 | Yes | - |
TP53 | 7157 | 2 | 0.432 | 0.944 | 564 | - | - |
PSMA1 | 5682 | 61 | 0.996 | 1.052 | 123 | Yes | - |
PSMD11 | 5717 | 121 | 1.095 | 1.106 | 183 | Yes | - |
ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
PSMA1 | 5682 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMD3 | 5709 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
PTGS2 | 5743 | TP53 | 7157 | pp | -- | int.I2D: BioGrid, BIND, HPRD; int.HPRD: in vivo |
PSMD1 | 5707 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast |
ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA2 | 5683 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA2 | 5683 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, Krogan_Core, MINT_Yeast, YeastLow, IntAct_Yeast |
PSMB7 | 5695 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct |
PSMA2 | 5683 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMA1 | 5682 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMA1 | 5682 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastLow, Krogan_Core, MINT_Yeast |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB7 | 5695 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
TP53 | 7157 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, BioGrid, MINT, StelzlHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA1 | 5682 | PSMA2 | 5683 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Worm, BioGrid, IntAct_Fly, IntAct_Worm, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
ACTB | 60 | PSMA1 | 5682 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD1 | 5707 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Krogan_Core |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PTGS2 | 5743 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid |
PSMA2 | 5683 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMA1 | 5682 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD11 | 5717 | TP53 | 7157 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, MINT, StelzlHigh, HPRD, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
RPA2 | 6118 | TP53 | 7157 | pp | -- | int.Transfac: - |
PSMD1 | 5707 | PTGS2 | 5743 | pp | -- | int.I2D: BioGrid, INNATEDB |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.88e-14 | 2.71e-10 | 7.038 | 7 | 19 | 64 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.16e-12 | 1.67e-08 | 7.172 | 6 | 17 | 50 |
GO:0000502 | proteasome complex | 2.94e-12 | 4.24e-08 | 6.958 | 6 | 17 | 58 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.98e-12 | 8.63e-08 | 6.794 | 6 | 22 | 65 |
GO:0000082 | G1/S transition of mitotic cell cycle | 8.27e-12 | 1.19e-07 | 5.819 | 7 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 8.67e-12 | 1.25e-07 | 5.810 | 7 | 24 | 150 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 9.48e-12 | 1.37e-07 | 6.687 | 6 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.13e-11 | 1.63e-07 | 6.646 | 6 | 20 | 72 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.34e-11 | 1.93e-07 | 6.607 | 6 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.45e-11 | 2.10e-07 | 6.587 | 6 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.00e-11 | 2.89e-07 | 6.512 | 6 | 23 | 79 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 5.12e-11 | 7.38e-07 | 6.293 | 6 | 21 | 92 |
GO:0000209 | protein polyubiquitination | 2.11e-10 | 3.04e-06 | 5.958 | 6 | 20 | 116 |
GO:0005654 | nucleoplasm | 3.12e-10 | 4.50e-06 | 3.474 | 10 | 76 | 1082 |
GO:0016032 | viral process | 1.46e-09 | 2.10e-05 | 4.170 | 8 | 55 | 534 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.22e-09 | 3.20e-05 | 5.398 | 6 | 20 | 171 |
GO:0000278 | mitotic cell cycle | 7.19e-09 | 1.04e-04 | 4.427 | 7 | 48 | 391 |
GO:0016071 | mRNA metabolic process | 1.09e-08 | 1.58e-04 | 5.015 | 6 | 31 | 223 |
GO:0043066 | negative regulation of apoptotic process | 1.26e-08 | 1.82e-04 | 4.311 | 7 | 31 | 424 |
GO:0016070 | RNA metabolic process | 2.01e-08 | 2.90e-04 | 4.868 | 6 | 32 | 247 |
GO:0006915 | apoptotic process | 8.06e-08 | 1.16e-03 | 3.922 | 7 | 33 | 555 |
GO:0005838 | proteasome regulatory particle | 9.64e-08 | 1.39e-03 | 8.231 | 3 | 7 | 12 |
GO:0010467 | gene expression | 2.89e-07 | 4.17e-03 | 3.653 | 7 | 59 | 669 |
GO:0022624 | proteasome accessory complex | 2.97e-07 | 4.29e-03 | 7.729 | 3 | 8 | 17 |
GO:0005839 | proteasome core complex | 3.57e-07 | 5.14e-03 | 7.646 | 3 | 8 | 18 |
GO:0004298 | threonine-type endopeptidase activity | 4.23e-07 | 6.10e-03 | 7.568 | 3 | 8 | 19 |
GO:0005829 | cytosol | 1.11e-06 | 1.61e-02 | 2.268 | 10 | 132 | 2496 |
GO:0044281 | small molecule metabolic process | 1.57e-05 | 2.27e-01 | 2.796 | 7 | 58 | 1211 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 1.77e-05 | 2.56e-01 | 8.231 | 2 | 4 | 8 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 3.48e-05 | 5.01e-01 | 7.772 | 2 | 4 | 11 |
GO:0030234 | enzyme regulator activity | 4.92e-05 | 7.10e-01 | 7.531 | 2 | 3 | 13 |
GO:0071456 | cellular response to hypoxia | 5.30e-05 | 7.64e-01 | 5.293 | 3 | 6 | 92 |
GO:0042176 | regulation of protein catabolic process | 7.57e-05 | 1.00e+00 | 7.231 | 2 | 3 | 16 |
GO:0034644 | cellular response to UV | 2.72e-04 | 1.00e+00 | 6.324 | 2 | 5 | 30 |
GO:0031625 | ubiquitin protein ligase binding | 3.75e-04 | 1.00e+00 | 4.340 | 3 | 14 | 178 |
GO:0006284 | base-excision repair | 4.16e-04 | 1.00e+00 | 6.022 | 2 | 3 | 37 |
GO:0003684 | damaged DNA binding | 7.30e-04 | 1.00e+00 | 5.616 | 2 | 7 | 49 |
GO:0090271 | positive regulation of fibroblast growth factor production | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0035633 | maintenance of blood-brain barrier | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0050473 | arachidonate 15-lipoxygenase activity | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0006302 | double-strand break repair | 1.17e-03 | 1.00e+00 | 5.277 | 2 | 4 | 62 |
GO:0019903 | protein phosphatase binding | 1.17e-03 | 1.00e+00 | 5.277 | 2 | 4 | 62 |
GO:0070062 | extracellular vesicular exosome | 1.27e-03 | 1.00e+00 | 1.810 | 7 | 104 | 2400 |
GO:0019899 | enzyme binding | 1.36e-03 | 1.00e+00 | 3.702 | 3 | 12 | 277 |
GO:0006289 | nucleotide-excision repair | 1.40e-03 | 1.00e+00 | 5.144 | 2 | 11 | 68 |
GO:0043234 | protein complex | 1.62e-03 | 1.00e+00 | 3.612 | 3 | 18 | 295 |
GO:0097252 | oligodendrocyte apoptotic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0009750 | response to fructose | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0032227 | negative regulation of synaptic transmission, dopaminergic | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:1901525 | negative regulation of macromitophagy | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0090343 | positive regulation of cell aging | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0004666 | prostaglandin-endoperoxide synthase activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0047485 | protein N-terminus binding | 2.23e-03 | 1.00e+00 | 4.805 | 2 | 5 | 86 |
GO:0016605 | PML body | 2.33e-03 | 1.00e+00 | 4.772 | 2 | 3 | 88 |
GO:0035794 | positive regulation of mitochondrial membrane permeability | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0051097 | negative regulation of helicase activity | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0006928 | cellular component movement | 2.49e-03 | 1.00e+00 | 4.723 | 2 | 7 | 91 |
GO:0002360 | T cell lineage commitment | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 2 | 3 |
GO:0034103 | regulation of tissue remodeling | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0090336 | positive regulation of brown fat cell differentiation | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0019788 | NEDD8 ligase activity | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 4 |
GO:0090403 | oxidative stress-induced premature senescence | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 4 |
GO:0002326 | B cell lineage commitment | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 4 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 5 |
GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0031622 | positive regulation of fever generation | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0071636 | positive regulation of transforming growth factor beta production | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0045986 | negative regulation of smooth muscle contraction | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0031915 | positive regulation of synaptic plasticity | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 5 |
GO:0030891 | VCB complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 5 |
GO:0070245 | positive regulation of thymocyte apoptotic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0007219 | Notch signaling pathway | 4.29e-03 | 1.00e+00 | 4.324 | 2 | 5 | 120 |
GO:0000790 | nuclear chromatin | 4.94e-03 | 1.00e+00 | 4.220 | 2 | 9 | 129 |
GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0010042 | response to manganese ion | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 3 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0030728 | ovulation | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0000733 | DNA strand renaturation | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 2 | 7 |
GO:0031497 | chromatin assembly | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 8 |
GO:0042633 | hair cycle | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 8 |
GO:0019372 | lipoxygenase pathway | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 9 |
GO:0006693 | prostaglandin metabolic process | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 2 | 9 |
GO:0031065 | positive regulation of histone deacetylation | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 9 |
GO:0005730 | nucleolus | 7.54e-03 | 1.00e+00 | 1.873 | 5 | 69 | 1641 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 10 |
GO:0071850 | mitotic cell cycle arrest | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 10 |
GO:0010226 | response to lithium ion | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 10 |
GO:0090399 | replicative senescence | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 10 |
GO:0071318 | cellular response to ATP | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 10 |
GO:0046902 | regulation of mitochondrial membrane permeability | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 10 |
GO:0008340 | determination of adult lifespan | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 11 |
GO:0009303 | rRNA transcription | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 11 |
GO:0001516 | prostaglandin biosynthetic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 12 |
GO:0051926 | negative regulation of calcium ion transport | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 12 |
GO:0070266 | necroptotic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 12 |
GO:0032461 | positive regulation of protein oligomerization | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 12 |
GO:0019371 | cyclooxygenase pathway | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 12 |
GO:0005662 | DNA replication factor A complex | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 4 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 14 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 14 |
GO:0033280 | response to vitamin D | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 14 |
GO:0001701 | in utero embryonic development | 1.16e-02 | 1.00e+00 | 3.580 | 2 | 8 | 201 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 14 |
GO:0070542 | response to fatty acid | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 14 |
GO:0009651 | response to salt stress | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 14 |
GO:0048568 | embryonic organ development | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 14 |
GO:0045987 | positive regulation of smooth muscle contraction | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 15 |
GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 16 |
GO:0050998 | nitric-oxide synthase binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 16 |
GO:0005634 | nucleus | 1.33e-02 | 1.00e+00 | 1.077 | 8 | 136 | 4559 |
GO:0042149 | cellular response to glucose starvation | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 17 |
GO:0051721 | protein phosphatase 2A binding | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 17 |
GO:0035861 | site of double-strand break | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 18 |
GO:0046697 | decidualization | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 18 |
GO:0005657 | replication fork | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 18 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 18 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0035035 | histone acetyltransferase binding | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0007369 | gastrulation | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0071158 | positive regulation of cell cycle arrest | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 2 | 19 |
GO:0010165 | response to X-ray | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 3 | 19 |
GO:0004601 | peroxidase activity | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0008156 | negative regulation of DNA replication | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 20 |
GO:0002931 | response to ischemia | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 20 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 20 |
GO:0006298 | mismatch repair | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 3 | 20 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 4 | 21 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 5 | 21 |
GO:0005669 | transcription factor TFIID complex | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 22 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 22 |
GO:0045907 | positive regulation of vasoconstriction | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 3 | 22 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 22 |
GO:0030863 | cortical cytoskeleton | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 4 | 22 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 3 | 23 |
GO:0006513 | protein monoubiquitination | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 1 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 4 | 23 |
GO:0005844 | polysome | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 4 | 23 |
GO:0071479 | cellular response to ionizing radiation | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 1 | 23 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 2 | 23 |
GO:0006281 | DNA repair | 1.91e-02 | 1.00e+00 | 3.203 | 2 | 18 | 261 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 7 | 24 |
GO:0001836 | release of cytochrome c from mitochondria | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 24 |
GO:0000060 | protein import into nucleus, translocation | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 5 | 24 |
GO:0043065 | positive regulation of apoptotic process | 2.01e-02 | 1.00e+00 | 3.165 | 2 | 10 | 268 |
GO:0000722 | telomere maintenance via recombination | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 25 |
GO:0007569 | cell aging | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 25 |
GO:0005515 | protein binding | 2.09e-02 | 1.00e+00 | 0.845 | 9 | 184 | 6024 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 4 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 3 | 26 |
GO:0034612 | response to tumor necrosis factor | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 4 | 27 |
GO:0010332 | response to gamma radiation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 3 | 28 |
GO:0019894 | kinesin binding | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 28 |
GO:0030282 | bone mineralization | 2.39e-02 | 1.00e+00 | 5.373 | 1 | 1 | 29 |
GO:0019005 | SCF ubiquitin ligase complex | 2.39e-02 | 1.00e+00 | 5.373 | 1 | 1 | 29 |
GO:0050873 | brown fat cell differentiation | 2.39e-02 | 1.00e+00 | 5.373 | 1 | 2 | 29 |
GO:0021549 | cerebellum development | 2.39e-02 | 1.00e+00 | 5.373 | 1 | 1 | 29 |
GO:0051262 | protein tetramerization | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 2 | 30 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 7 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 2 | 30 |
GO:0046677 | response to antibiotic | 2.55e-02 | 1.00e+00 | 5.277 | 1 | 2 | 31 |
GO:0016604 | nuclear body | 2.55e-02 | 1.00e+00 | 5.277 | 1 | 2 | 31 |
GO:0001756 | somitogenesis | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 33 |
GO:0030971 | receptor tyrosine kinase binding | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 33 |
GO:0033077 | T cell differentiation in thymus | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 33 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 33 |
GO:0001085 | RNA polymerase II transcription factor binding | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 33 |
GO:0019901 | protein kinase binding | 2.75e-02 | 1.00e+00 | 2.923 | 2 | 21 | 317 |
GO:0001895 | retina homeostasis | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 34 |
GO:0007566 | embryo implantation | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 1 | 35 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 3 | 35 |
GO:0034332 | adherens junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 1 | 36 |
GO:0051402 | neuron apoptotic process | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.04e-02 | 1.00e+00 | 5.022 | 1 | 4 | 37 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 3.04e-02 | 1.00e+00 | 5.022 | 1 | 2 | 37 |
GO:0070527 | platelet aggregation | 3.12e-02 | 1.00e+00 | 4.983 | 1 | 2 | 38 |
GO:0003723 | RNA binding | 3.16e-02 | 1.00e+00 | 2.813 | 2 | 20 | 342 |
GO:0000781 | chromosome, telomeric region | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 3 | 39 |
GO:0045786 | negative regulation of cell cycle | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 1 | 39 |
GO:0008285 | negative regulation of cell proliferation | 3.35e-02 | 1.00e+00 | 2.768 | 2 | 11 | 353 |
GO:0019369 | arachidonic acid metabolic process | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 42 |
GO:0021762 | substantia nigra development | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 2 | 44 |
GO:0034613 | cellular protein localization | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 1 | 44 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 2 | 44 |
GO:0007612 | learning | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 1 | 45 |
GO:0050727 | regulation of inflammatory response | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 3 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 7 | 46 |
GO:0005507 | copper ion binding | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 2 | 46 |
GO:0019233 | sensory perception of pain | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 1 | 48 |
GO:0003743 | translation initiation factor activity | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 8 | 49 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 4 | 49 |
GO:0035690 | cellular response to drug | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 2 | 49 |
GO:0016020 | membrane | 4.22e-02 | 1.00e+00 | 1.516 | 4 | 90 | 1681 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 5 | 53 |
GO:0007613 | memory | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 53 |
GO:0045216 | cell-cell junction organization | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 2 | 54 |
GO:0000932 | cytoplasmic mRNA processing body | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 3 | 54 |
GO:0097193 | intrinsic apoptotic signaling pathway | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 6 | 55 |
GO:0002039 | p53 binding | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 7 | 55 |
GO:0000724 | double-strand break repair via homologous recombination | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 3 | 55 |
GO:0008104 | protein localization | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 3 | 56 |
GO:0000723 | telomere maintenance | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 6 | 56 |
GO:0008217 | regulation of blood pressure | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 4 | 57 |
GO:0051087 | chaperone binding | 4.80e-02 | 1.00e+00 | 4.348 | 1 | 6 | 59 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 4.96e-02 | 1.00e+00 | 4.300 | 1 | 2 | 61 |
GO:0005901 | caveola | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 5 | 62 |
GO:0051384 | response to glucocorticoid | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 2 | 62 |
GO:0071260 | cellular response to mechanical stimulus | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 5 | 65 |
GO:0007596 | blood coagulation | 5.32e-02 | 1.00e+00 | 2.401 | 2 | 18 | 455 |
GO:0035264 | multicellular organism growth | 5.44e-02 | 1.00e+00 | 4.165 | 1 | 1 | 67 |
GO:0003697 | single-stranded DNA binding | 5.52e-02 | 1.00e+00 | 4.144 | 1 | 5 | 68 |
GO:0034329 | cell junction assembly | 5.52e-02 | 1.00e+00 | 4.144 | 1 | 1 | 68 |
GO:0044267 | cellular protein metabolic process | 5.72e-02 | 1.00e+00 | 2.342 | 2 | 29 | 474 |
GO:0032355 | response to estradiol | 5.75e-02 | 1.00e+00 | 4.081 | 1 | 5 | 71 |
GO:0000785 | chromatin | 5.91e-02 | 1.00e+00 | 4.041 | 1 | 4 | 73 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 6 | 74 |
GO:0002020 | protease binding | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 2 | 75 |
GO:0008584 | male gonad development | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 3 | 75 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 3 | 75 |
GO:0007265 | Ras protein signal transduction | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 2 | 75 |
GO:0006979 | response to oxidative stress | 7.01e-02 | 1.00e+00 | 3.788 | 1 | 3 | 87 |
GO:0016363 | nuclear matrix | 7.32e-02 | 1.00e+00 | 3.723 | 1 | 12 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 7.32e-02 | 1.00e+00 | 3.723 | 1 | 8 | 91 |
GO:0020037 | heme binding | 7.47e-02 | 1.00e+00 | 3.692 | 1 | 2 | 93 |
GO:0014069 | postsynaptic density | 8.40e-02 | 1.00e+00 | 3.517 | 1 | 3 | 105 |
GO:0008289 | lipid binding | 8.47e-02 | 1.00e+00 | 3.503 | 1 | 1 | 106 |
GO:0030308 | negative regulation of cell growth | 8.78e-02 | 1.00e+00 | 3.450 | 1 | 6 | 110 |
GO:0015630 | microtubule cytoskeleton | 8.78e-02 | 1.00e+00 | 3.450 | 1 | 4 | 110 |
GO:0006461 | protein complex assembly | 8.86e-02 | 1.00e+00 | 3.437 | 1 | 6 | 111 |
GO:0072562 | blood microparticle | 8.86e-02 | 1.00e+00 | 3.437 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 8 | 112 |
GO:0006325 | chromatin organization | 9.39e-02 | 1.00e+00 | 3.348 | 1 | 5 | 118 |
GO:0032496 | response to lipopolysaccharide | 9.62e-02 | 1.00e+00 | 3.312 | 1 | 4 | 121 |
GO:0006260 | DNA replication | 9.62e-02 | 1.00e+00 | 3.312 | 1 | 9 | 121 |
GO:0007050 | cell cycle arrest | 9.85e-02 | 1.00e+00 | 3.277 | 1 | 9 | 124 |
GO:0009615 | response to virus | 1.00e-01 | 1.00e+00 | 3.254 | 1 | 5 | 126 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.00e-01 | 1.00e+00 | 3.254 | 1 | 5 | 126 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.01e-01 | 1.00e+00 | 3.231 | 1 | 4 | 128 |
GO:0006413 | translational initiation | 1.04e-01 | 1.00e+00 | 3.198 | 1 | 17 | 131 |
GO:0006457 | protein folding | 1.13e-01 | 1.00e+00 | 3.071 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 1.14e-01 | 1.00e+00 | 3.051 | 1 | 7 | 145 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.16e-01 | 1.00e+00 | 3.031 | 1 | 3 | 147 |
GO:0006974 | cellular response to DNA damage stimulus | 1.19e-01 | 1.00e+00 | 2.993 | 1 | 8 | 151 |
GO:0043005 | neuron projection | 1.23e-01 | 1.00e+00 | 2.937 | 1 | 6 | 157 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.29e-01 | 1.00e+00 | 2.865 | 1 | 7 | 165 |
GO:0030424 | axon | 1.30e-01 | 1.00e+00 | 2.856 | 1 | 4 | 166 |
GO:0044212 | transcription regulatory region DNA binding | 1.31e-01 | 1.00e+00 | 2.839 | 1 | 6 | 168 |
GO:0032403 | protein complex binding | 1.42e-01 | 1.00e+00 | 2.715 | 1 | 10 | 183 |
GO:0001525 | angiogenesis | 1.48e-01 | 1.00e+00 | 2.654 | 1 | 4 | 191 |
GO:0005759 | mitochondrial matrix | 1.74e-01 | 1.00e+00 | 2.398 | 1 | 14 | 228 |
GO:0006412 | translation | 1.75e-01 | 1.00e+00 | 2.386 | 1 | 20 | 230 |
GO:0008134 | transcription factor binding | 1.84e-01 | 1.00e+00 | 2.312 | 1 | 8 | 242 |
GO:0004842 | ubiquitin-protein transferase activity | 1.93e-01 | 1.00e+00 | 2.237 | 1 | 6 | 255 |
GO:0008270 | zinc ion binding | 1.99e-01 | 1.00e+00 | 1.270 | 2 | 12 | 997 |
GO:0006954 | inflammatory response | 2.08e-01 | 1.00e+00 | 2.117 | 1 | 7 | 277 |
GO:0042493 | response to drug | 2.12e-01 | 1.00e+00 | 2.081 | 1 | 13 | 284 |
GO:0005856 | cytoskeleton | 2.17e-01 | 1.00e+00 | 2.046 | 1 | 12 | 291 |
GO:0016567 | protein ubiquitination | 2.20e-01 | 1.00e+00 | 2.027 | 1 | 5 | 295 |
GO:0030154 | cell differentiation | 2.24e-01 | 1.00e+00 | 1.998 | 1 | 5 | 301 |
GO:0007275 | multicellular organismal development | 2.34e-01 | 1.00e+00 | 1.927 | 1 | 5 | 316 |
GO:0007411 | axon guidance | 2.35e-01 | 1.00e+00 | 1.914 | 1 | 13 | 319 |
GO:0005813 | centrosome | 2.40e-01 | 1.00e+00 | 1.882 | 1 | 14 | 326 |
GO:0008283 | cell proliferation | 2.41e-01 | 1.00e+00 | 1.874 | 1 | 14 | 328 |
GO:0003682 | chromatin binding | 2.41e-01 | 1.00e+00 | 1.878 | 1 | 11 | 327 |
GO:0005925 | focal adhesion | 2.65e-01 | 1.00e+00 | 1.715 | 1 | 19 | 366 |
GO:0046982 | protein heterodimerization activity | 2.74e-01 | 1.00e+00 | 1.661 | 1 | 13 | 380 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.94e-01 | 1.00e+00 | 1.541 | 1 | 15 | 413 |
GO:0005524 | ATP binding | 2.95e-01 | 1.00e+00 | 0.889 | 2 | 60 | 1298 |
GO:0046872 | metal ion binding | 2.98e-01 | 1.00e+00 | 0.879 | 2 | 25 | 1307 |
GO:0055114 | oxidation-reduction process | 2.99e-01 | 1.00e+00 | 1.517 | 1 | 12 | 420 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.33e-01 | 1.00e+00 | 1.330 | 1 | 13 | 478 |
GO:0042802 | identical protein binding | 3.36e-01 | 1.00e+00 | 1.312 | 1 | 20 | 484 |
GO:0005783 | endoplasmic reticulum | 3.76e-01 | 1.00e+00 | 1.112 | 1 | 10 | 556 |
GO:0005789 | endoplasmic reticulum membrane | 3.84e-01 | 1.00e+00 | 1.076 | 1 | 16 | 570 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.84e-01 | 1.00e+00 | 1.076 | 1 | 16 | 570 |
GO:0005737 | cytoplasm | 3.86e-01 | 1.00e+00 | 0.352 | 4 | 110 | 3767 |
GO:0042803 | protein homodimerization activity | 3.97e-01 | 1.00e+00 | 1.014 | 1 | 12 | 595 |
GO:0045087 | innate immune response | 3.97e-01 | 1.00e+00 | 1.012 | 1 | 24 | 596 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 4.49e-01 | 1.00e+00 | 0.782 | 1 | 11 | 699 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.91e-01 | 1.00e+00 | 0.607 | 1 | 19 | 789 |
GO:0005615 | extracellular space | 5.61e-01 | 1.00e+00 | 0.329 | 1 | 17 | 957 |
GO:0006355 | regulation of transcription, DNA-templated | 5.77e-01 | 1.00e+00 | 0.270 | 1 | 18 | 997 |
GO:0005739 | mitochondrion | 5.77e-01 | 1.00e+00 | 0.268 | 1 | 28 | 998 |
GO:0044822 | poly(A) RNA binding | 5.99e-01 | 1.00e+00 | 0.187 | 1 | 49 | 1056 |
GO:0003677 | DNA binding | 6.53e-01 | 1.00e+00 | -0.019 | 1 | 28 | 1218 |